ArticleNature communications2026

XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures.

Yueting Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.